Adam S. Grossman, President and CEO at ADMA BIOLOGICS, INC. (ADMA), bought 30,000 shares at $4.00 ($120K) on 2019-05-17, disclosed to the SEC on 2019-05-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.00 | 5,000 | $20K | 16.7% |
| 2 | $4.00 | 25,000 | $100K | 83.3% |
| Total | $4.00 avg | 30,000 | $120K | 100% |
| Filing → |
| ADMA | SELL | 2025-12-16 | $416K | — | Filing → |
| ADMA | SELL | 2025-11-21 | $336K | — | Filing → |
| ADMA | SELL | 2025-10-24 | $336K | — | Filing → |